Literature DB >> 22754008

l-Asparaginase Production by Moderate Halophilic Bacteria Isolated from Maharloo Salt Lake.

Alireza Ebrahiminezhad1, Sara Rasoul-Amini, Younes Ghasemi.   

Abstract

l-Asparaginase is an anti-neoplastic drug used in lymphoblastic leukemia chemotherapy. Nowadays, this enzyme derived from bacterial sources, mostly l-asparaginase II from Escherichia coli and in lesser amount l-asparaginase of Erwinia sp. has medical utilization. The long-term usage of these agents leads to allergic reactions and new asparaginase with new immunological characteristics is required. Halophilic bacteria might contain l-asparaginase with novel immunological properties that can be used in hypersensitive patients. In this experiment, we have screened moderate Halophilic bacteria for l-asparaginase production ability and showed that Halophilic bacteria produce intra- and extracellular l-asparaginase. Bacillus sp. BCCS 034 was found to produce the highest l-asparaginase (1.64 IU/ml supernatant) extracellularly.

Entities:  

Keywords:  16S rRNA; Bacteria; Halophile; l-Asparaginase

Year:  2011        PMID: 22754008      PMCID: PMC3209906          DOI: 10.1007/s12088-011-0158-6

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  13 in total

1.  Screening and isolation of halophilic bacteria producing extracellular hydrolyses from Howz Soltan Lake, Iran.

Authors:  R Rohban; Mohammad Ali Amoozegar; A Ventosa
Journal:  J Ind Microbiol Biotechnol       Date:  2008-11-27       Impact factor: 3.346

2.  A rapid plate assay for screening L-asparaginase producing micro-organisms.

Authors:  R Gulati; R K Saxena; R Gupta
Journal:  Lett Appl Microbiol       Date:  1997-01       Impact factor: 2.858

3.  L-Asparaginase production by the rumen anaerobe Vibrio succinogenes.

Authors:  D Kafkewitz; D Goodman
Journal:  Appl Microbiol       Date:  1974-01

4.  Production of L-asparaginase II by Escherichia coli.

Authors:  H Cedar; J H Schwartz
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

5.  Two L-asparaginases from E. coli and their action against tumors.

Authors:  J H Schwartz; J Y Reeves; J D Broome
Journal:  Proc Natl Acad Sci U S A       Date:  1966-11       Impact factor: 11.205

6.  L-asparaginase production by various bacteria.

Authors:  R E Peterson; A Ciegler
Journal:  Appl Microbiol       Date:  1969-06

7.  Miniprep DNA isolation from unicellular and filamentous cyanobacteria.

Authors:  M F Fiore; D H Moon; S M Tsai; H Lee; J T Trevors
Journal:  J Microbiol Methods       Date:  2000-01       Impact factor: 2.363

8.  L-Asparaginase production by Streptomyces griseus.

Authors:  P J DeJong
Journal:  Appl Microbiol       Date:  1972-06

9.  Asparagine utilization in Escherichia coli.

Authors:  R C Willis; C A Woolfolk
Journal:  J Bacteriol       Date:  1974-04       Impact factor: 3.490

10.  Production of L-asparaginase by filamentous fungi.

Authors:  Maria Inez de Moura Sarquis; Edna Maria Morais Oliveira; Alberdan Silva Santos; Gisela Lara da Costa
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-11-03       Impact factor: 2.743

View more
  5 in total

1.  Isolation and screening of extracellular anticancer enzymes from halophilic and halotolerant bacteria from different saline environments in Iran.

Authors:  Mahdis Zolfaghar; Mohammad Ali Amoozegar; Khosro Khajeh; Hamid Babavalian; Hamid Tebyanian
Journal:  Mol Biol Rep       Date:  2019-04-16       Impact factor: 2.316

2.  Cloning, expression and characterization of L-asparaginase from Pseudomonas fluorescens for large scale production in E. coli BL21.

Authors:  Vijay Kishore; K P Nishita; H K Manonmani
Journal:  3 Biotech       Date:  2015-04-05       Impact factor: 2.406

Review 3.  Recent Strategies and Applications for l-Asparaginase Confinement.

Authors:  João C F Nunes; Raquel O Cristóvão; Mara G Freire; Valéria C Santos-Ebinuma; Joaquim L Faria; Cláudia G Silva; Ana P M Tavares
Journal:  Molecules       Date:  2020-12-10       Impact factor: 4.411

4.  Combinatorial approach for screening and assessment of multiple therapeutic enzymes from marine isolate Pseudomonas aeruginosa AR01.

Authors:  Yogeswaran Jagadeesan; Shanmugapriya Meenakshisundaram; Lokha Ranjani Alagar Boopathy; Vijay Pradhap Singh Mookandi; Anandaraj Balaiah
Journal:  RSC Adv       Date:  2019-05-31       Impact factor: 4.036

5.  The potential of halophilic and halotolerant bacteria for the production of antineoplastic enzymes: L-asparaginase and L-glutaminase.

Authors:  Pejman Shirazian; Sedigheh Asad; Mohammad Ali Amoozegar
Journal:  EXCLI J       Date:  2016-04-18       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.